Contact us at if you are interested in becoming a beta site for our patented "SPICE" technology. As a member of the Quantitative Imaging Network (QIN), which grew from a National Cancer Institute (NCI) sponsored program designed to develop imaging methods for the measurement of tumor response to therapies, IB extends a special invite to all participating QIN sites.


"SPICE [Dual-Echo] meets a long needed breakthrough in perfusion imaging."

- Sotirios Bisdas, MD, PhD, MSc (Advanced Oncology), Professor of Radiology, Eberhard Karls University


SPICE is the patented MR acquisition and post-processing technology that:

  1. Uses a SINGLE, standard dose of Gd contrast agent (no more pre-load required)
  2. Does NOT require the acquisition of pre-contrast T1 data
  3. Provides BOTH DSC and DCE parameters simultaneously
  4. Results in BETTER image quality

Save time. Save material. Simplify workflows. Obtain more information.

IB's policy on Promoting Objectivity in Research.